Development of Cancer Treatments with No Side Effects

Development of Cancer Treatments with No Side Effects

Direct Approach to Disease Stem Cells

Pathological stem cells, which become dysfunctional, hide within niches and deny access to drugs. Today, methods have been developed to activate these niches, pushing pathological stem cells into accessible spaces.

Thus, drugs using Biozipcode technology can be either newly developed drugs or previously developed drugs that could not be used due to side effects. Target-coded nanodrones will ensure delivery only to target cells.

Utilizing Biozipcode Technology

Next-Generation Drug Delivery System

For humans, cell banks and cultured cells are available for use. The system that delivers drugs only to target cells works like nanodrones within the body. This method can identify sequences that do not interact with any cells in the body. Since these sequences do not react with normal cells, they are potential candidates for targeting cancer stem cells that do not naturally exist in the body. The number of approximately one billion codes is considered more than sufficient to cover all possibilities.

Utilizing Biozipcode Technology

Discovery of the Cause of Diabetes

Discovery of Diabetes Stem Cells

Abnormal cells causing diabetes and its complications discovered in hematopoietic stem cells.

Complete Remission of Diabetes

Establishing a treatment method using “HDAC inhibitors” + “insulin.”

Diagnostic Drugs for Diabetes

Developing companion diagnostic drugs to diagnose diabetes based on the presence of diabetes stem cells in peripheral blood.

Biozipcode (Cell Targeting Technology)

Biozipcode (Cell Targeting Technology)

An innovative system for delivering drugs exclusively to specific cells in the body.

New Diabetes Cure Drugs

Development of entirely new diabetes cure drugs using Biozipcode.

Anti-Cancer Drugs with No Side Effects

Development of new drugs using Biozipcode and reuse of drugs previously unusable due to side effects.

Tissue Regeneration via Cell Targeting

Development of materials for tissue regeneration that can engraft onto tissues without needing transplants or sutures.